Results 41 to 50 of about 212 (60)

ЭФФЕКТИВНОСТЬ И БЕЗОПАСНОСТЬ АПИКСАБАНА С ТОЧКИ ЗРЕНИЯ КЛИНИЧЕСКОГО ФАРМАКОЛОГА

Медицинский совет, 2017
Антикоагулянтная терапия – эффективный инструмент борьбы с такими серьезными заболеваниями, как фибрилляция предсердий и тромбоз глубоких вен. Именно они чаще всего провоцируют грозные осложнения, уносящие жизнь, – кар-диоэмболический инсульт и ...

doaj  

ЭФФЕКТИВНОСТЬ И БЕЗОПАСНОСТЬ ДАБИГАТРАНА У ПОЖИЛЫХ БОЛЬНЫХ С НЕКЛАПАННОЙ ФИБРИЛЛЯЦИЕЙ ПРЕДСЕРДИЙ В РЕАЛЬНОЙ КЛИНИЧЕСКОЙ ПРАКТИКЕ (РЕЗУЛЬТАТЫ ИССЛЕДОВАНИЯ MEDICARE)

Атеротромбоз, 2015
В обзорной статье рассмотрены результаты наблюдательного когортного исследования Medicare, целью которого являлось получение дополнительной информации об эффективности и безопасности дабигатрана у более чем 130 тыс.
Н. М. Воробьева, Е. П. Панченко   +1 more
doaj   +1 more source

Analysis of antithrombotic therapy of atrial fibrillation in international and Russian registries

Качественная клиническая практика, 2019
In the article the features of the organization of international and Russian registers of patients with atrial fibrillation (AF), the clinical and demographic characteristics of patients included in the registers, as well as the features of ...
O. V. Reshetko, A. V. Sokolov, N. V. Furman   +2 more
doaj   +1 more source

Comparison of biatrial and left atrial radiofrequency ablation in patients with heart valves diseases

Патология кровообращения и кардиохирургия, 2015
We analysed results of left atrial and biatrial anatomic scheme of radiofrequency (RF) ablation of the atria in patients with valvular heart. From 2007 to 2011, RF ablation procedure performed 283 patients with atrial fibrillation and heart valve disease.
А. В. Богачев-прокофьев, С. И. Железнев, А. Н. Пивкин, А. М. Караськов   +3 more
doaj   +1 more source

[Type 2 amiodarone-induced thyrotoxicosis: prevalence, time and predictors of development]. [PDF]

Probl Endokrinol (Mosk), 2023
Ermolaeva AS, Fadeev VV.
europepmc   +1 more source

[Russian eligibility criteria prescribing menopausal hormonal hormones therapy for patients with cardiovascular and metabolic diseases. Consensus document of the Russian Cardiological Society, Russian Society of Obstetricians and Gynecologists, Russian Association of Endocrinologists, Eurasian Association of Therapists, Association of Phlebologists of Russia]. [PDF]

Probl Endokrinol (Mosk), 2023
Shlyakhto EV, Sukhikh GT, Serov VN, Dedov II, Arutyunov GP, Suchkov IA, Orlova YA, Andreeva EN, Yureneva SV, Yavelov IS, Yarmolinskaya MI, Villevalde SV, Grigoryan OR, Dudinskaya EN, Ilyukhin EA, Koziolova NA, Sergienko IV, Smetnik AA, Tapilskaya NI.   +18 more
europepmc   +1 more source

CHANGE OF LOCAL MYOCARDIAL CONTRACTILITY DUE TO SELECTION OF DIFFERENT ARRHYTHMIA TREATMENT STRATEGIES IN PATIENTS WITH ISCHEMIC HEART DISEASE AND PAROXYSMAL ATRIAL FIBRILLATION

Рациональная фармакотерапия в кардиологии, 2015
Aim. To study the change of local myocardial contractility in patients with ischemic heart disease (IHD) and paroxysmal atrial fibrillation (AF) during treatment with amiodarone 200 mg daily compared with bisoprolol therapy 5 mg daily.Material and ...
V. I. Podzolkov, A. I. Tarzimanova
doaj   +1 more source

[Thyrotropin-secreting pituitary adenomas: clinical features and results of treatment in 45 patients]. [PDF]

Probl Endokrinol (Mosk), 2023
Trukhina DA, Przhiyalkovskaya EG, Belaya ZE, Grigoriev AY, Azizyan VN, Mamedova EO, Rozhinskaya LY, Lapshina AM, Pigarova EA, Dzeranova LK, Platonova NM, Troshina EA, Melnichenko GA.   +12 more
europepmc   +1 more source

[Telomere pathology in ontogenesis in patients with Turner syndrome]. [PDF]

Probl Endokrinol (Mosk), 2022
Mikheev RK, Grigoryan OR, Pankratova MS, Andreeva EN, Sheremetyeva EV, Absatarova YS, Mokrysheva NG.   +6 more
europepmc   +1 more source

[Use of metformin in patients with type 2 diabetes and acute myocardial infarction: safety and impact on glycemic control]. [PDF]

Probl Endokrinol (Mosk), 2023
Korotina MA, Pochinka IG, Strongin LG.
europepmc   +1 more source